BiPASS (Biopsy of the Prostate Avoidance Stratification Study 1) is the first registration-enabling study to evaluate whether the combination of MRI 2 and PSMA-PET 3 imaging ... prospective, open ...
Accuray Incorporated ( NASDAQ: ARAY) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT ...
The PRIME trial tested whether the dynamic contrast enhancement sequence in multiparametric MRI is truly necessary to improve significant prostate cancer ...
Dr. Wallen: PSA can vary even day by day in patients for a lot of reasons. First of all, PSA is not a cancer specific test.
Biparametric MRI, which omits dynamic contrast-enhanced sequences, similarly detected clinically significant prostate cancer to multiparametric MRI. Biparametric MRI was also noninferior to ...
Art Imaging By Trish Yerges for Grande Ronde Hospital September is Prostate Cancer Awareness Month—a reminder that men age 50 ...
Millions of men could benefit from a new, faster prostate cancer scan. The quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer in clinical trials as the current 30- to ...
A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...
“For whatever reasons men might choose to not proactively seek care, it is important to educate these men that there are ...
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...
Scan.com offers fast, accessible private scans including MRI, CT and ultrasound, with results in days and no GP referral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback